Crossref
Response to second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer: make no assumptions
Current Oncology · 2012
DOI: 10.3747//co.19.949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2012. Verfasst von I. Karam und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Karam, I., & Melosky, B. (2012). Response to second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer: make no assumptions. Current Oncology. https://doi.org/10.3747//co.19.949
Vancouver
Karam I, Melosky B. Response to second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer: make no assumptions. Current Oncology. 2012. doi:10.3747//co.19.949
BibTeX
@article{Karam2012,
author = {Karam, I. and Melosky, B.},
title = {Response to second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer: make no assumptions},
journal = {Current Oncology},
year = {2012},
doi = {10.3747//co.19.949}
}
EUVIMED